Sutidiazine (ZY-19489) is an orally active and antimalarial agent. Sutidiazine inhibits parasitemia-induced infection. Sutidiazine shows short half-lives (approximately 7 h) and an exposure effect.
References:
[1]. Ghoghari AM, et al. Simultaneous estimation of ZY-19489 and its active metaboliteZY-20486 in human plasma using LC-MS/MS, a novel antimalarial compound. Bioanalysis. 2021 Dec;13(23):1761-1777.
















